Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan

被引:25
作者
Tseng, Chin-Hsiao [1 ,2 ,3 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Med Res & Dev, Yunlin, Taiwan
关键词
Albuminuria; Dyslipidemia; Lipoprotein(a); Apolipoprotein B; Triglyceride; Type; 2; diabetes; HUMAN MESANGIAL CELLS; LIPOPROTEIN(A) LEVELS; APOLIPOPROTEIN-B; KIDNEY-DISEASE; EXCRETION RATE; RENIN RELEASE; RISK; LDL; PROGRESSION; PHENOTYPES;
D O I
10.1016/j.clinbiochem.2009.03.013
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: This study evaluated the lipid abnormalities associated with different stages of albuminuria in type 2 diabetic patients. Methods and results: A total of 549 patients (245 men and 304 women) with mean age of 63.4 were studied. Normoalbuminuria (n=251), microalbuminuria (n=242) and macroalbuminuria (n=56) were defined as albumin-to-creatinine ratio of < 30, 30-299 and >= 300 mu g/mg, respectively. Lipid parameters included total cholesterol, triglyceride (TG), high- and low-density lipoprotein (LDL) cholesterol, apolipoproteins A1 and B (ApoB), and lipoprotein(a) [Lp(a)]. Results showed that ApoB differed significantly (p < 0.05) between normoalbuminuria and microalbuminuria/macroalbuminuria and Ln[Lp(a)] differed between normoalbuminuria/microalbuminuria and macroalbuminuria. Ln(TG) increased progressively with increasing albuminuria. In multivariate logistic regression analyses, only ApoB showed significant odds ratio (95% confidence interval) for microalbuminuria: 1.013 (1.004-1.022); and both ln(TG) and ln[Lp(a)] were significant for macroalbuminuria [respective odds ratios: 1.995 (1.010-3.938) and 1.708 (1.200-2.430)]. Conclusions: A differential dyslipidemia is observed for microalbuminuria and macroalbuminuria. Apo(B) and Lp(a) increase at the stages of microalbuminuria and macroalbuminuria, respectively. However, TG increases significantly throughout the three stages of albuminuria. (c) 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:1019 / 1024
页数:6
相关论文
共 25 条
  • [1] Standards of Medical Care in Diabetes-2009
    不详
    [J]. DIABETES CARE, 2009, 32 : S13 - S61
  • [2] Dyslipidemia in patients with type 2 diabetes. Relationships between lipids, kidney disease and cardiovascular disease
    Battisti, WP
    Palmisano, J
    Keane, WF
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (09) : 1174 - 1181
  • [3] Lipoprotein(a) levels and risk of future coronary heart disease
    Bennet, Anna
    Di Angelantonio, Ernanuele
    Erqou, Sebhat
    Eiriksdottir, Gudny
    Sigurdsson, Gunnar
    Woodward, Mark
    Rumley, Ann
    Lowe, Gordon D. O.
    Danesh, John
    Gudnason, Vilmundur
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (06) : 598 - 608
  • [4] Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients
    Boemi, M
    Sirolla, C
    Fumelli, P
    James, RW
    [J]. DIABETES CARE, 1999, 22 (12) : 2033 - 2036
  • [5] Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels
    Boizel, R
    Benhamou, PY
    Lardy, B
    Laporte, F
    Foulon, T
    Halimi, S
    [J]. DIABETES CARE, 2000, 23 (11) : 1679 - 1685
  • [6] Lipoprotein (a) (Lp(a)): a possible link between migraine and stroke
    Cinzia, Fatini
    Daniela, Poli
    Elena, Sticchi
    Francesco, Sofi
    Emilia, Antonucci
    Sandra, Fedi
    Graziano, Arnetoli
    Domenico, Prisco
    Rosanna, Abbate
    [J]. TRANSLATIONAL RESEARCH, 2009, 153 (01) : 44 - 47
  • [7] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE
    COCKCROFT, DW
    GAULT, MH
    [J]. NEPHRON, 1976, 16 (01) : 31 - 41
  • [8] De Sain-Van der Velden MGM, 1998, J AM SOC NEPHROL, V9, P1474
  • [9] Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia
    Demacker, PNM
    Veerkamp, MJ
    Bredie, SJH
    Marcovina, SM
    de Graaf, J
    Stalenhoef, AFH
    [J]. ATHEROSCLEROSIS, 2000, 153 (02) : 483 - 490
  • [10] Effect of HDL and atherogenic lipoproteins on formation of O-2(-) and renin release in juxtaglomerular cells
    Galle, J
    Heinloth, A
    Schwedler, S
    Wanner, C
    [J]. KIDNEY INTERNATIONAL, 1997, 51 (01) : 253 - 260